Screening Frequency
| Timeline | Screening Tool |
| Pre-Conception | PHQ-9 GAD-7 Review safety of psych meds |
| Intake | EPDS + GAD-7 ANRQ |
| 26-28 weeks gestation | EPDS + GAD-7 |
| Six weeks postpartum | EPDS + GAD-7 ANRQ (post partum) |
If your patient is high-risk, we recommend additional screening with the EPDS at 2 weeks postpartum.
We recommend asking "How is your bond with your baby?" at any postpartum visit.
Screening Tools
Interactive Screening Tool
A quick and easy way to screen your patients for depression and/or anxiety with an option to print or email the results.
Depression
Edinburgh Postnatal Depression Scale (EPDS) (Form-fillable; Printable; English)
The EPDS has been translated into many other languages, including French, and these versions can be found here.
Anxiety
GAD-7 Patient Screening Tool (Form fillable; Printable; English)
GAD-7 (French)
Depression and Anxiety Combined Screening
Combined EPDS and GAD-7 Screening Tool (Form fillable; Printable; English)
ANRQ (Psychosocial) Risk Questionnaire
ANRQ with Family Violence & Drug/Alcohol Questions - Client
ANRQ Postnatal Version with FV & D+A Questions - Client
Additional Screening
| If your patients scores... | Consider screening for... |
| Positive on the EPDS | Bipolar Disorder with the MDQ |
| Positive for Q10 on the EPDS | Suicide Risk with the C-SSRS |
| Positive on the GAD-7 | PTSD with the PCL-5 |
Why screen for bipolar disorder?
- It is important to screen for bipolar disorder because 1 in 5 patients who screen positive for perinatal depression may have bipolar disorder.
- Treating with an unopposed antidepressant can induce mania, mixed states, and rapid cycling, all of which carry significant risks.
- Bipolar disorder is associated with increased risk of postpartum psychosis and postpartum psychosis is associated with suicide and infanticide.
Bipolar Disorder
Suicide Risk Assessment Tool
Columbia-Suicide Severity Rating Scale (C-SSRS) - PDF
PTSD